Dual-target weight-loss drug is 47% more effective than its rival | “Our study shows that treatment with tirzepatide was superior to semaglutide with respect to reduction in body weight and waist circumference."
https://ift.tt/1AcLvM9
Submitted May 13, 2025 at 03:57PM by chrisdh79 https://ift.tt/BGnf6Uv via TikTokTikk
No comments:
Post a Comment